MARY HILL: Open Payments
NPI 1104311489 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 8 payments from 5 companies in 2025. Trend: 2023 $361 · 2024 $232 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Abbott Laboratories | 1 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Alkermes, Inc. | 1 | $15 |
Products named: INGREZZA, ETERNA, INVEGA SUSTENNA, AUSTEDO XR, ARISTADA.
Industry payments across LA — which companies pay providers there.
